Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
- DOI
- 10.1038/9035
- Published
- 1999 May
- Container
- Nature cell biology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/9035,
title = {Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.},
author = {Hoessel R and Leclerc S and Endicott JA and Nobel ME and Lawrie A and Tunnah P and Leost M and Damiens E and Marie D and Marko D and Niederberger E and Tang W and Eisenbrand G and Meijer L},
year = {1999},
journal = {Nature cell biology},
doi = {10.1038/9035},
url = {https://doi.org/10.1038/9035}
}RIS
TY - JOUR TI - Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. AU - Hoessel R AU - Leclerc S AU - Endicott JA AU - Nobel ME AU - Lawrie A AU - Tunnah P AU - Leost M AU - Damiens E AU - Marie D AU - Marko D AU - Niederberger E AU - Tang W AU - Eisenbrand G AU - Meijer L PY - 1999 JO - Nature cell biology DO - 10.1038/9035 UR - https://doi.org/10.1038/9035 ER -
APA
R, H., S, L., JA, E., ME, N., A, L., P, T., M, L., E, D., D, M., D, M., E, N., W, T., G, E., & L, M. (1999). Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.. Nature cell biology. https://doi.org/10.1038/9035
Source records
- pubmed · retrieved 2026-09-25T13:34:20.814Z